Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07683338Completed
Randomised trial of pregabalin in diabetic peripheral neuropathy (DPN) (2 arms), sponsored by Syeda Khatoon e Jannat Welfare Foundation. Primary endpoint: Pain intensity at 12 weeks. Started Feb 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07683338.